V
Verastem Inc (VSTM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$7.41
-0.29 (-3.77%)
Market Cap: $970.31M
Last updated: Nov 17, 2026 at 4:35 PM ET
Verastem Inc (VSTM) Valuation Multiples
Verastem (VSTM) trades at 7.5x sales and 74.3x book value. Its P/S of 7.5x is below its 5-year median of 37.9x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 7.5x |
| Price to book | 74.3x |
| PEG | N/A |
Historical Medians
Against its 10-year medians, its P/B is 1963.9% above 3.6x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 7.5x | 37.9x | N/A |
| P/B | 74.3x | 4.2x | 3.6x |
Valuation History
Over the 7 of the 10 year ends shown that have a P/S, its P/S ranged from 3.9x in 2020 to 179.7x in 2021.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $7.72 | 19.5x | 11.3x |
| 2024 | $5.17 | 47.1x | N/A |
| 2023 | $8.14 | N/A | 3.8x |
| 2022 | $4.83 | 15.1x | 1.7x |
| 2021 | $24.61 | 179.7x | 4.3x |
| 2020 | $25.57 | 3.9x | 3.1x |
| 2019 | $16.09 | 5.7x | 14.3x |
| 2018 | $40.34 | 9.0x | 2.3x |
| 2017 | $36.85 | N/A | 2.2x |
| 2016 | $13.45 | N/A | 0.6x |
Frequently Asked Questions About VSTM
What is VSTM's price to sales ratio?
Verastem has a price to sales ratio of 7.5x.
VSTM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors